Cash Cash Equivalents - Nanobiotix SA (PAR:NANO) - Alpha Spread

Nanobiotix SA
PAR:NANO

Watchlist Manager
Nanobiotix SA Logo
Nanobiotix SA
PAR:NANO
Watchlist
Price: 4.584 EUR -1.33%
Market Cap: 217.3m EUR
Have any thoughts about
Nanobiotix SA?
Write Note

Nanobiotix SA
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nanobiotix SA
Cash & Cash Equivalents Peer Comparison

Comparables:
VLA
IPH
GNFT
ALERS
OSE

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Nanobiotix SA
PAR:NANO
Cash & Cash Equivalents
€75.3m
CAGR 3-Years
-14%
CAGR 5-Years
16%
CAGR 10-Years
31%
Valneva SE
PAR:VLA
Cash & Cash Equivalents
€131.4m
CAGR 3-Years
-26%
CAGR 5-Years
24%
CAGR 10-Years
15%
Innate Pharma SA
PAR:IPH
Cash & Cash Equivalents
€70m
CAGR 3-Years
-12%
CAGR 5-Years
-14%
CAGR 10-Years
-1%
Genfit SA
NASDAQ:GNFT
Cash & Cash Equivalents
€77.8m
CAGR 3-Years
-23%
CAGR 5-Years
-18%
CAGR 10-Years
14%
Eurobio Scientific SA
PAR:ALERS
Cash & Cash Equivalents
€89m
CAGR 3-Years
11%
CAGR 5-Years
52%
CAGR 10-Years
32%
OSE Immunotherapeutics SA
PAR:OSE
Cash & Cash Equivalents
€12.6m
CAGR 3-Years
-25%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is Nanobiotix SA's Cash & Cash Equivalents?
Cash & Cash Equivalents
75.3m EUR

Based on the financial report for Dec 31, 2023, Nanobiotix SA's Cash & Cash Equivalents amounts to 75.3m EUR.

What is Nanobiotix SA's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
31%

Over the last year, the Cash & Cash Equivalents growth was 95%. The average annual Cash & Cash Equivalents growth rates for Nanobiotix SA have been -14% over the past three years , 16% over the past five years , and 31% over the past ten years .

Back to Top